Vitexin exerts protective effects against calcium oxalate crystal-induced kidney pyroptosis in vivo and in vitro

Atorvastatin inhibits renal inflammatory response induced by calcium oxalate crystals via inhibiting the activation of TLR4/NF‐κB and NLRP3 inflammasome

(2020) Yan Sun et al.   IUBMB LIFE

Vitexin attenuates myocardial ischemia/reperfusion injury in rats by regulating mitochondrial dysfunction induced by mitochondrial dynamics imbalance

(2020) Wei Xue et al.   BIOMEDICINE & PHARMACOTHERAPY

Possible Epigenetic Role of Vitexin in Regulating Neuroinflammation in Alzheimer’s Disease

(2020) M. A. F. Yahaya et al.   Journal of Immunology Research

Vitexin ameliorates chronic stress plub high fat diet-induced nonalcoholic fatty liver disease by inhibiting inflammation

(2020) Chujie Li et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Long noncoding RNA LINC00339 promotes renal tubular epithelial pyroptosis by regulating the miR-22-3p/NLRP3 axis in calcium oxalate-induced kidney stone

(2019) Zhengyao Song et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Loss of the androgen receptor suppresses intrarenal calcium oxalate crystals deposition via altering macrophage recruitment/M2 polarization with change of the miR-185-5p/CSF-1 signals

(2019) Wei Zhu et al.   Cell Death & Disease

LncRNA HOXA11‐AS regulates calcium oxalate crystal–induced renal inflammation via miR‐124‐3p/MCP‐1

(2019) Yinhui Li et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Gasdermin D and pyroptosis in acute kidney injury

(2019) Wulf Tonnus et al.   KIDNEY INTERNATIONAL

Mechanisms of Gasdermin Family Members in Inflammasome Signaling and Cell Death

(2018) Shouya Feng et al.   JOURNAL OF MOLECULAR BIOLOGY

The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1–mediated tissue injury

(2018) Hans-Joachim Anders et al.   KIDNEY INTERNATIONAL

Losartan Ameliorates Calcium Oxalate-Induced Elevation of Stone-Related Proteins in Renal Tubular Cells by Inhibiting NADPH Oxidase and Oxidative Stress

(2018) Baolong Qin et al.   Oxidative Medicine and Cellular Longevity

Gastrin-releasing peptide receptor gene silencing inhibits the development of the epithelial-mesenchymal transition and formation of a calcium oxalate crystal in renal tubular epithelial cells in mice with kidney stones via the PI3K/Akt signaling pathway

(2018) Xin-Fang Wang et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Oxalate, inflammasome, and progression of kidney disease

(2016) Theresa Ermer et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice

(2016) Isis Ludwig-Portugall et al.   KIDNEY INTERNATIONAL

Kidney stones

(2016) Saeed R. Khan et al.   Nature Reviews Disease Primers

An update on the role of the inflammasomes in the pathogenesis of kidney diseases

(2015) Murthy N. Darisipudi et al.   PEDIATRIC NEPHROLOGY

Cardioprotection of Vitexin on Myocardial Ischemia/Reperfusion Injury in Rat via Regulating Inflammatory Cytokines and MAPK Pathway

(2013) Liu-Yi Dong et al.   AMERICAN JOURNAL OF CHINESE MEDICINE

Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease

(2013) S. R. Mulay et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Canonical and non-canonical effects of the NLRP3 inflammasome in kidney inflammation and fibrosis

(2013) Georg Lorenz et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1β secretion

(2012) Shrikant R. Mulay et al.   JOURNAL OF CLINICAL INVESTIGATION

Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis

(2011) Hans-Joachim Anders et al.   KIDNEY INTERNATIONAL

New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis

(2009) Y. Liu   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY